On behalf of the Mediterranean League against Thromboembolic Diseases (MLTD), we take great pleasure in inviting you to attend the 22nd International Congress on Thrombosis in Nice (October 6-9, 2012). Nice has been chosen for the venue of this meeting because of its location on the Mediterranean sea, its dynamic university and its accessibility. The Congress Center, Acropolis, is an attractive place in downtown Nice with a modern and functional structure.

The most important is the program of the sessions, combining both clinical and biological aspects of thrombosis which is the aim of MLTD congresses. We have planned plenary sessions, symposia and educational sessions on up-to-date subjects, all presented by outstanding lecturers. In addition, we trust on your willing to send abstracts on original new findings.

New antithrombotics, antiplatelet agents and anticoagulants, are now available. Their mode of action, indications, doses and side-effects need to be clarified, as well as their influence on laboratory tests . In 2012, the place of ‘old’ antithrombotics such as aspirin, clopidogrel, vitamin K antagonists and heparins will be important to consider. Guidelines have been published in different countries for treatment and prevention of thrombosis: they must be known and followed by clinicians in the real life.

New approaches based on cellular interactions, proteomics and genomics will be presented and discussed.

Women’s Health is also a major topic. Pregnancy, hormonal treatments for contraception, menopause or breast cancer are associated with an increased risk of thrombosis, and a more recent area concerns all assisted reproductive technologies. Other original themes on the latest research will be developed.

We hope many of you will attend this congress and we look forward to welcoming you for a very ‘Nice’ meeting.

President Jean-François Schved
Vice-President Jacqueline Conard